H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report
Summary
H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
H. Lundbeck A/S (Lundbeck or 'the company') is engaged in research, development, production and sale of pharmaceuticals mainly concentrating on central nervous system (CNS) disorders. The company’s products are focused on treating depression/anxiety, Alzheimer’s disease, schizophrenia, alcohol dependence, Parkinson’s disease, epilepsy, Lennox-gastaut syndrome, Huntington's disease, psychotic disorders, symptomatic neurogenic orthostatic hypotension, and bipolar disorders. Lundbeck markets its products under Abilify Maintena, Abixa, Azilect, Brintellix, Celexa, and Cipralex brands names. It manages manufacturing facilities in China, Italy, Denmark, and France. Lundbeck sells its products to distributors of pharmaceuticals, hospitals, and pharmacies. The company is headquartered in Valby, Denmark.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook